The Impact of NF-κB and Keap1/Caspase-3 Signaling Pathway on protective Effects of sitagliptin in a Rat Model of Doxorubicin-Induced Cardiac Dysfunction. | ||
| Bulletin of Egyptian Society for Physiological Sciences | ||
| Volume 45, Issue 3, July 2025, Pages 347-361 PDF (826.5 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/besps.2025.362914.1204 | ||
| Authors | ||
| mahmoud mostafa* 1; Enas M. Kasem1; Walaa H. Mohammed1; Manar A. Elkholy2; Alzahraa Z. Elsayed2; Eman Mohamed Faruk3; mona kamal el awam1 | ||
| 1Department of Physiology, Faculty of Medicine, Benha University, Benha, Egypt. | ||
| 2Department of Pharmacology, Faculty of Medicine, Benha University, Qalubiya, Egypt. | ||
| 3Anatomy Department, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia, Department of Histology and Cell Biology, Faculty of Medicine, Benha University, Benha, Egypt | ||
| Abstract | ||
| Background: Doxorubicin (DOX) treatment is a primary cause of chemotherapy-induced cardiotoxicity. Antidiabetic sitagliptin (STG) has been shown to improve cardiovascular functions through anti-inflammatory, antioxidant, and anti-apoptotic effects. Oxidative stress plays a crucial role in the development of various cardiovascular diseases, especially those related to endothelial dysfunction. The transcription factor nuclear factor erythroid-2-like 2 (Nrf2) is the main regulator of antioxidant defense mechanisms. Nrf2, along with its suppressor protein Kelch-like ECH-associated protein 1 (Keap1), controls the levels of reactive oxygen species (ROS). Objective: This study aimed to evaluate the role of the Nrf2/caspase-3 signaling pathway in the cardiotoxic effect of DOX and the potential role of sitagliptin (STG). Materials and Methods: Rats were divided into four groups, each comprising eight animals (n=8): a control group, an STG group (receiving 10 mg/kg/day for 21 days), a DOX group (receiving 1mg/kg i.p per day for five injections \ week for 3 weeks) and STG+DOX group (treated by STG and DOX as previously mentioned). Results: The effect of DOX on cardiac tissue detected a significant reduction in ABP, and deviated ST segment, while STG improved DOX-induced cardiotoxicity markers, oxidative stress and inflammatory markers. Also, STG regulate cardiovascular hemodynamics and reduce both cardiac caspase-3, Keap-1 and upregulates NrF2 gene expression levels Conclusion: STG administration can exert protective effects against doxorubicin-induced cardiac toxicity through anti-inflammatory, antioxidant, and anti-apoptotic properties, in addition to promoting the Nrf2 signaling pathway. | ||
| Keywords | ||
| cardiac toxicity; nuclear factor erythroid 2-related factor 2 (Nrf2); Doxorubicin; caspase-3 | ||
|
Statistics Article View: 153 PDF Download: 77 |
||
